A case of vitiligo after COVID-19 vaccination: a possible role of thymic dysfunction.

Author: Denis KUZNETSOV ¹ ; Oleg KALYUZHIN ² ; Andrey MIRONOV ³ ; Valery NESCHISLIAEV ⁴ ; Anastasiia KUZNETSOVA ⁴
Author Information

1. G N. Gabrichevsky Scientific and Research Institute of Epidemiology and Microbiology, Moscow 125212, Russia. denis.pfa@gmail.com.
2. I M. Sechenov First Moscow State Medical University, Moscow 119991, Russia.
3. G N. Gabrichevsky Scientific and Research Institute of Epidemiology and Microbiology, Moscow 125212, Russia.
4. Perm State Pharmaceutical Academy, Perm 614990, Russia.
Publication Type:Journal Article
MeSH: Humans; COVID-19/prevention & control*; COVID-19 Vaccines/adverse effects*; Vaccination/adverse effects*; Vitiligo/etiology*; Thymus Gland/physiopathology*
From: Journal of Zhejiang University. Science. B 2023;24(12):1141-1150
CountryChina
Language:English
Abstract: During the coronavirus disease 2019 (COVID-19) pandemic, vaccines help control the spread of infection. To date, 47 vaccines have been approved, with another 227 candidates in various stages of development. In the short period of time since the beginning of their use, evidence has begun to emerge of complications following vaccination in the form of the development or exacerbation of a number of pathological conditions (Block et al., 2022; Haseeb et al., 2022). For example, a population-based study in France identified 1612 cases of myocarditis and 1613 cases of pericarditis requiring hospital treatment within five months of vaccination (le Vu et al., 2022).